Loading insider details...
Beta
Latest Form 4 (Jun 16, 2026): Grant/Award of 9,810 QTTB shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 16, 2026 | Q32 Bio Inc. (QTTB) | Grant/Award | 9,810 | n/a |
| Jan 7, 2026 | Inhibikase Therapeutics, Inc. (IKT) | Grant/Award | 4,982,706 | n/a |
| Dec 12, 2025 | Merus N.V. (MRUS) | Tender of Shares | 73,576 | $7.14M |
| Dec 9, 2025 | Akero Therapeutics, Inc. (AKRO) | Disposition to Issuer | 9,398 | n/a |
| Oct 28, 2025 | Q32 Bio Inc. (QTTB) | Grant/Award | 53,521 | n/a |
| Oct 25, 2025 | KALA BIO, Inc. (KALA) | Sale | 154,894 | $125.5K |
| Jun 27, 2025 | KALA BIO, Inc. (KALA) | Sale | 13,227 | $53.0K |
| Jun 18, 2025 | KALA BIO, Inc. (KALA) | Grant/Award | 2,450 | n/a |
| Jun 5, 2025 | Akero Therapeutics, Inc. (AKRO) | Grant/Award | 9,398 | n/a |
| Jun 5, 2025 | KALA BIO, Inc. (KALA) | Sale | 10,866 | $40.6K |